These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6628527)

  • 1. Pharmacokinetics of fenclofenac in children with juvenile rheumatoid arthritis.
    Mäkelä AL; Scheinin M; Iisalo E; Salonen JS
    Eur J Clin Pharmacol; 1983; 25(3):381-8. PubMed ID: 6628527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of fenclofenac following single and multiple doses.
    Henson R; Lloyd-Jones JG; Nichols JD; Jordan BJ
    Eur J Drug Metab Pharmacokinet; 1980; 5(4):217-23. PubMed ID: 7250145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of juvenile rheumatoid arthritis with diclofenac sodium.
    Haapasaari J; Wuolijoki E; Ylijoki H
    Scand J Rheumatol; 1983; 12(4):325-30. PubMed ID: 6361986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolism of fenclofenac in the horse.
    Marsh MV; Caldwell J; Sloan TP; Smith RL; Horner M; Moss MS
    Xenobiotica; 1983 Apr; 13(4):233-40. PubMed ID: 6624138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.
    Giannini EH; Brewer EJ; Person DA
    Ann Rheum Dis; 1984 Apr; 43(2):228-31. PubMed ID: 6424588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of dose and concentration-effect relationships for fenclofenac in rheumatoid arthritis.
    Dunagan FM; McGill PE; Kelman AW; Whiting B
    Br J Clin Pharmacol; 1986 Apr; 21(4):409-16. PubMed ID: 3518772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics.
    Albertioni F; Flatø B; Seideman P; Beck O; Vinje O; Peterson C; Eksborg S
    Eur J Clin Pharmacol; 1995; 47(6):507-11. PubMed ID: 7768253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naproxen absorption in children.
    Ansell BM; Hanna DB; Stoppard M
    Curr Med Res Opin; 1975; 3(1):46-50. PubMed ID: 1167825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High response rate in the phase I/II study of meloxicam in juvenile rheumatoid arthritis.
    Foeldvari I; Burgos-Vargas R; Thon A; Tuerck D
    J Rheumatol; 2002 May; 29(5):1079-83. PubMed ID: 12022326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of pirprofen in children with juvenile chronic arthritis.
    Hallé F; Marfil F; Sioufi A; Dubois JP; Gioud-Paquet M; Lenoir G; Prieur AM
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):29-34. PubMed ID: 1936058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady state pharmacokinetics of piroxicam in children with rheumatic diseases.
    Mäkelä AL; Olkkola KT; Mattila MJ
    Eur J Clin Pharmacol; 1991; 41(1):79-81. PubMed ID: 1782984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis.
    Wallace CA; Bleyer WA; Sherry DD; Salmonson KL; Wedgwood RJ
    Arthritis Rheum; 1989 Jun; 32(6):677-81. PubMed ID: 2735961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study.
    Ruperto N; Brunner HI; Zuber Z; Tzaribachev N; Kingsbury DJ; Foeldvari I; Horneff G; Smolewska E; Vehe RK; Hazra A; Wang R; Mebus CA; Alvey C; Lamba M; Krishnaswami S; Stock TC; Wang M; Suehiro R; Martini A; Lovell DJ; ;
    Pediatr Rheumatol Online J; 2017 Dec; 15(1):86. PubMed ID: 29282090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis.
    Pachman LM; Olufs R; Procknal JA; Levy G
    Arthritis Rheum; 1979 Aug; 22(8):826-31. PubMed ID: 465097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of the active metabolite of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis.
    Shi J; Kovacs SJ; Wang Y; Ludden TM; Bhargava VO
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):419-39. PubMed ID: 16284916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of proquazone and its m-hydroxy metabolite by high-performance liquid chromatography. Clinical application: pharmacokinetics of proquazone in children with juvenile rheumatoid arthritis.
    Lempiäinen M; Mäkelä AL
    J Chromatogr; 1985 May; 341(1):105-13. PubMed ID: 4019675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.
    Reiff A; Lovell DJ; Adelsberg JV; Kiss MH; Goodman S; Zavaler MF; Chen PY; Bolognese JA; Cavanaugh P; Reicin AS; Giannini EH
    J Rheumatol; 2006 May; 33(5):985-95. PubMed ID: 16583464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis.
    Goodman S; Howard P; Haig A; Flavin S; Macdonald B
    J Rheumatol; 2003 Apr; 30(4):829-31. PubMed ID: 12672207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of meloxicam in patients with juvenile rheumatoid arthritis.
    Burgos-Vargas R; Foeldvari I; Thon A; Linke R; Tuerck D
    J Clin Pharmacol; 2004 Aug; 44(8):866-72. PubMed ID: 15286090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.